Complement activation has been implicated in the pathogenesis of catastrophic antiphospholipid syndrome (CAPS), a rare lifethreatening disease

Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome

Lotti, Virginia;Carletto, Antonio;Biasi, Domenico
2021-01-01

Abstract

Complement activation has been implicated in the pathogenesis of catastrophic antiphospholipid syndrome (CAPS), a rare lifethreatening disease
Antiphospholipid Syndrome
Biomarkers
Catastrophic Illness
Complement C5a
Complement Inactivating Agents
Complement Membrane Attack Complex
Complement Activation
File in questo prodotto:
File Dimensione Formato  
Blood_letter_2021.pdf

solo utenti autorizzati

Tipologia: Versione dell'editore
Licenza: Accesso ristretto
Dimensione 234.82 kB
Formato Adobe PDF
234.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1058669
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
social impact